Preventative effects of morinda citrifolia on mammary breast cancer

Details for Australian Patent Application No. 2004291030 (hide)

Owner Morinda, Inc.

Inventors Wang, Mian-Ying; Su, Chen; Jensen, Claude Jarakae

Agent Cullen & Co

Pub. Number AU-B-2004291030

PCT Pub. Number WO2005/048919

Priority 10/639,833 12.08.03 US

Filing date 11 August 2004

Wipo publication date 2 June 2005

Acceptance publication date 20 September 2007

International Classifications

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/048919 Priority application(s): WO2005/048919

20 September 2007 Application Accepted

  Published as AU-B-2004291030

17 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291037-Combination therapy comprising the use of ET-743 and paclitaxel for treating cancer

2004291026-Use of EphA4 and modulator or EphA4 for diagnosis, treatment and prevention of cancer